Breast Cancer

• CLINICAL_TRIALS research · 2025-08-15
  Clinical Trial Update: Randomized, Open, Controlled, Multicenter Phase III Clinical Study of Fluzoparib in Combination With Apatinib Versus Investigator-Selected Chemotherapy for HRD-Positive/HER2-negative Advanced Breast Cancer [Phase 3]

  A Phase III randomized trial is evaluating Fluzoparib in combination with Apatinib versus investigator-selected chemotherapy for HRD-positiv…

• CLINICAL_TRIALS research · 2025-08-15
  Clinical Trial Update: A Study on the Treatment of Early Small Breast Cancer With Ultrasound-guided Vacuum-assisted Excision Combined With Surgery [NA]

  This document reports a clinical trial evaluating ultrasound-guided vacuum-assisted excision combined with surgery for early breast cancer, …

• CLINICAL_TRIALS trial_result · 2025-08-14
  Clinical Trial Update: 'OLAP' (OLAparib Regulatory Post-marketing Surveillance)

  A post-marketing surveillance trial of olaparib (Lynparza) conducted by AstraZeneca has completed, reporting safety monitoring results acros…

• CLINICAL_TRIALS trial_result · 2025-08-14
  Clinical Trial Update: Pecha Kucha Method Effects on Posttraumatic Growth and Psychological Resilience [NA]

  A completed clinical trial from Istanbul Sabahattin Zaim University evaluated the Pecha Kucha method for improving posttraumatic growth and …

• CLINICAL_TRIALS research · 2025-08-14
  Clinical Trial Update: Impact of 18F-FES PET on the Therapeutic Treatment of Patients With Metastatic Breast Cancer [Phase 4]

  Phase 4 clinical trial update evaluating whether 18F-FES PET imaging can influence therapeutic decisions for patients with metastatic breast…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2025-08-14
  Clinical Trial Update: Artificial Intelligence in Breast Cancer Screening Programs [NA]

  The document notes the completion of a clinical trial evaluating artificial intelligence in breast cancer screening programs, sponsored by M…

• CLINICAL_TRIALS research · 2025-08-14
  Clinical Trial Update: Clinical Trial of TQB2102 for Injection Versus Trastuzumab Emtansine for Injection in HER2-positive Advanced Breast Cancer [Phase 3]

  Phase 3 trial comparing TQB2102 to Trastuzumab Emtansine for HER2-positive metastatic breast cancer is currently recruiting.

• CLINICAL_TRIALS research · 2025-08-14
  Clinical Trial Update: The Effect of Walking and Grounding in Women With Breast Cancer [NA]

  A clinical trial entry for a study on the effects of walking and grounding in women with breast cancer; currently recruiting.

• CLINICAL_TRIALS research · 2025-08-14
  Clinical Trial Update: Psychological Well-being in Patients With Breast Cancer

  This document reports a clinical trial evaluating psychological well-being in patients with breast cancer that is currently recruiting.

• CLINICAL_TRIALS research · 2025-08-14
  Clinical Trial Update: A Targeted Electronic Health Approach to Reduce Fear of Recurrence in Breast Cancer Survivors (FoRtitude) [NA]

  The FoRtitude trial tests a targeted electronic health intervention to reduce fear of cancer recurrence among breast cancer survivors. The s…

• CLINICAL_TRIALS research · 2025-08-14
  Clinical Trial Update: PERformance of Multi-Cancer Early-detectIon Based on Various Biomarkers in fEmale BREAST Cancers, PERCEIVE-BREAST

  This record reports an active-not-recruiting clinical trial called PERCEIVE-BREAST, studying multi-cancer early-detection biomarkers with a …

• CLINICAL_TRIALS trial_result · 2025-08-13
  Clinical Trial Update: Evaluating Investigational Medical Device for Breast Tumor Diagnosis Using Diffusion Optical Spectroscopy [Phase 3]

  Phase 3 trial evaluating an investigational diffusion optical spectroscopy device for diagnosing breast tumors has completed.

• CLINICAL_TRIALS trial_result · 2025-08-13
  Clinical Trial Update: Efficacy of Pulsed Electromagnetic Field Therapy on Acute Radiodermatitis in Breast Cancer Patients [NA]

  The trial evaluated pulsed electromagnetic field therapy for acute radiodermatitis in breast cancer patients and is reported as completed.

• CLINICAL_TRIALS trial_result · 2025-08-13
  Clinical Trial Update: CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer [Phase 1]

  Phase 1 clinical trial evaluating a combination of a CD40 agonist, FLT3 ligand, and chemotherapy in HER2-negative breast cancer. The study i…

• CLINICAL_TRIALS trial_result · 2025-08-13
  Clinical Trial Update: PECS II vs. MTP for Analgesia After MRM [NA]

  A completed clinical trial at Ain Shams University compared PECS II block with MTP for analgesia after modified radical mastectomy; results …

• CLINICAL_TRIALS research · 2025-08-13
  Clinical Trial Update: Breast Cancer Risk Investigation in Grown-up Hodgkin Lymphoma Patients Treated With MBVD. Multicenter Retrospective Study on ≥200 Adult Female HL Patients Treated With ≥1 MBVD Cycle (NPLD, Bleomycin, Vinblastine, Dacarbazine). It Investigates Breast Cancer Incidence Post-treatment.

  This multicenter retrospective study evaluates the incidence of breast cancer in adult female Hodgkin lymphoma survivors treated with MBVD (…

• CLINICAL_TRIALS research · 2025-08-13
  Clinical Trial Update: Discontinuation of Maintenance HER-2 Directed Therapy in Long-Term Survivors of Metastatic HER-2 Positive Breast Cancer [NA]

  A clinical trial (NCT05959291) sponsored by the University of Miami is evaluating discontinuation of maintenance HER-2 directed therapy in l…

• CLINICAL_TRIALS research · 2025-08-13
  Clinical Trial Update: Evaluation of Cognitive Management for Chemobrain in Patients Treated for Breast Cancer. [NA]

  Clinical trial update from Institut Bergonié evaluating cognitive management strategies for chemotherapy-related cognitive impairment in bre…

• CLINICAL_TRIALS research · 2025-08-13
  Clinical Trial Update: Impact of Intermittent Fasting on Biomarkers of Inflammation and Health-Related Quality of Life: A Feasibility Trial for Women With HR+/HER2- Early Breast Cancer [NA]

  Feasibility trial evaluating intermittent fasting's impact on inflammation biomarkers and health-related quality of life in women with hormo…

• CLINICAL_TRIALS research · 2025-08-13
  Clinical Trial Update: Study of Molecular Characterisation of Early Operable Primary Breast Cancer in Pakistani Population

  This study aims to molecularly characterize early operable primary breast cancer in the Pakistani population and is currently recruiting.

• CLINICAL_TRIALS research · 2025-08-12
  Clinical Trial Update: A Phase I Study of [68Ga]Ga-DWJ155 in Patients With Breast and Lung Cancers [Phase 1]

  Phase I clinical trial update for the radiopharmaceutical [68Ga]Ga-DWJ155 in patients with breast cancer and non-small cell lung cancer; the…

• CLINICAL_TRIALS research · 2025-08-12
  Clinical Trial Update: Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers [Phase 1]

  Phase 1 clinical trial examining the biodistribution of the Ga-68 labeled imaging tracer 68Ga-FAPi-46 in patients with solid tumors and hema…

• CLINICAL_TRIALS research · 2025-08-12
  Clinical Trial Update: A Novel Patient Decision Aid for Surgical Treatment Options in Early-Stage Breast Cancer [NA]

  This clinical trial update describes the development of a novel patient decision aid to help patients choose surgical treatment options for …

• EMA approval · 2025-08-12
  EMA Authorised: Naveruclif (paclitaxel) — Accord Healthcare S.L.U.

  EMA authorised Naveruclif (paclitaxel) by Accord Healthcare S.L.U. for breast cancer, pancreatic cancer, and non-small cell lung cancer.

• CLINICAL_TRIALS research · 2025-08-12
  Clinical Trial Update: Exploration of the Safety and Efficacy of T-DXd Concurrent With Brain Radiotherapy in Patients With Brain Metastases HER2-positive/HER2-low Advanced Breast Cancer [NA]

  A clinical trial is exploring the safety and efficacy of trastuzumab deruxtecan (T-DXd) given concurrently with brain radiotherapy in patien…